A Phase 3, Randomized, Placebo-Controlled, Double-Blind Study of Oral Ixazomib Maintenance Therapy After Initial Therapy in Patients With Newly Diagnosed Multiple Myeloma Not Treated With Stem Cell Transplantation

Type of Cancer
Multiple Myeloma

Site
Bethesda

Sponsor
Millenium

Protocol Number
C16021

To Learn More Call
201-510-0910